These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2530761)

  • 21. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
    Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
    Psychopharmacol Bull; 1989; 25(2):267-71. PubMed ID: 2532373
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1990 Apr; 18(4):289-99. PubMed ID: 2140382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
    Kuhs H; Schlake HP; Rolf LH; Rudolf GA
    Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind comparison of paroxetine and placebo in the treatment of depressed outpatients.
    Claghorn J
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():25-30. PubMed ID: 1431007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.
    Schlake HP; Kuhs H; Rolf LH; Bosse T; Schuhknecht E; Rudolf GA; Brune GG
    Acta Psychiatr Scand Suppl; 1989; 350():149-51. PubMed ID: 2530775
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety.
    Chaudhry HR; Qureshi Z; Tareen IA; Yazdani I
    J Pak Med Assoc; 2002 Nov; 52(11):518-25. PubMed ID: 12585372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients.
    Byrne MM
    Acta Psychiatr Scand Suppl; 1989; 350():138-9. PubMed ID: 2530768
    [No Abstract]   [Full Text] [Related]  

  • 31. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
    Ravindran AV; Judge R; Hunter BN; Bray J; Morton NH
    J Clin Psychiatry; 1997 Mar; 58(3):112-8. PubMed ID: 9108813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients.
    Feighner JP
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():31-5. PubMed ID: 1431008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
    Dunner DL; Cohn JB; Walshe T; Cohn CK; Feighner JP; Fieve RR; Halikas JP; Hartford JT; Hearst ED; Settle EC
    J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder.
    Ratti E; Bellew K; Bettica P; Bryson H; Zamuner S; Archer G; Squassante L; Bye A; Trist D; Krishnan KR; Fernandes S
    J Clin Psychopharmacol; 2011 Dec; 31(6):727-33. PubMed ID: 22020354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
    Szegedi A; Wetzel H; Angersbach D; Dunbar GC; Schwarze H; Philipp M; Benkert O
    Pharmacopsychiatry; 1997 May; 30(3):97-105. PubMed ID: 9211571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
    Schöne W; Ludwig M
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of an NK1 receptor antagonist to an SSRI did not enhance the antidepressant effects of SSRI monotherapy: results from a randomized clinical trial in patients with major depressive disorder.
    Ball WA; Snavely DB; Hargreaves RJ; Szegedi A; Lines C; Reines SA
    Hum Psychopharmacol; 2014 Nov; 29(6):568-77. PubMed ID: 25330122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.